535 related articles for article (PubMed ID: 33766256)
1. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
Thavendiranathan P; Zhang L; Zafar A; Drobni ZD; Mahmood SS; Cabral M; Awadalla M; Nohria A; Zlotoff DA; Thuny F; Heinzerling LM; Barac A; Sullivan RJ; Chen CL; Gupta D; Kirchberger MC; Hartmann SE; Weinsaft JW; Gilman HK; Rizvi MA; Kovacina B; Michel C; Sahni G; González-Mansilla A; Calles A; Fernández-Avilés F; Mahmoudi M; Reynolds KL; Ganatra S; Gavira JJ; González NS; García de Yébenes Castro M; Kwong RY; Jerosch-Herold M; Coelho-Filho OR; Afilalo J; Zataraín-Nicolás E; Baksi AJ; Wintersperger BJ; Calvillo-Arguelles O; Ederhy S; Yang EH; Lyon AR; Fradley MG; Neilan TG
J Am Coll Cardiol; 2021 Mar; 77(12):1503-1516. PubMed ID: 33766256
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.
Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
Eur Radiol; 2022 Nov; 32(11):7657-7667. PubMed ID: 35567603
[TBL] [Abstract][Full Text] [Related]
3. Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.
Cadour F; Cautela J; Rapacchi S; Varoquaux A; Habert P; Arnaud F; Jacquier A; Meilhac A; Paganelli F; Lalevée N; Scemama U; Thuny F
Radiology; 2022 Jun; 303(3):512-521. PubMed ID: 35230185
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
Zhang L; Awadalla M; Mahmood SS; Nohria A; Hassan MZO; Thuny F; Zlotoff DA; Murphy SP; Stone JR; Golden DLA; Alvi RM; Rokicki A; Jones-O'Connor M; Cohen JV; Heinzerling LM; Mulligan C; Armanious M; Barac A; Forrestal BJ; Sullivan RJ; Kwong RY; Yang EH; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Moslehi JJ; Coelho-Filho OR; Ganatra S; Rizvi MA; Sahni G; Tocchetti CG; Mercurio V; Mahmoudi M; Lawrence DP; Reynolds KL; Weinsaft JW; Baksi AJ; Ederhy S; Groarke JD; Lyon AR; Fradley MG; Thavendiranathan P; Neilan TG
Eur Heart J; 2020 May; 41(18):1733-1743. PubMed ID: 32112560
[TBL] [Abstract][Full Text] [Related]
5. Applying quantitative CMR parameters for detecting myocardial lesion in immune checkpoint inhibitors-associated myocarditis.
Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
Eur J Radiol; 2022 Nov; 156():110558. PubMed ID: 36265221
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
Higgins AY; Arbune A; Soufer A; Ragheb E; Kwan JM; Lamy J; Henry M; Cuomo JR; Charifa A; Gallegos C; Hull S; Coviello JS; Bader AS; Peters DC; Huber S; Mojibian HR; Sinusas AJ; Kluger H; Baldassarre LA
PLoS One; 2021; 16(2):e0246764. PubMed ID: 33606757
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitor-related myocarditis: an illustrative case series of applying the updated Cardiovascular Magnetic Resonance Lake Louise Criteria.
Wintersperger BJ; Calvillo-Argüelles O; Lheureux S; Houbois CP; Spreafico A; Bedard PL; Neilan TG; Thavendiranathan P
Eur Heart J Case Rep; 2022 Jan; 6(1):ytab478. PubMed ID: 35079688
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of cardiovascular magnetic resonance native T1 and T2 mapping in pediatric patients with acute myocarditis.
Cornicelli MD; Rigsby CK; Rychlik K; Pahl E; Robinson JD
J Cardiovasc Magn Reson; 2019 Jul; 21(1):40. PubMed ID: 31307467
[TBL] [Abstract][Full Text] [Related]
9. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques.
Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M
Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700
[TBL] [Abstract][Full Text] [Related]
10. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging.
Radunski UK; Lund GK; Stehning C; Schnackenburg B; Bohnen S; Adam G; Blankenberg S; Muellerleile K
JACC Cardiovasc Imaging; 2014 Jul; 7(7):667-75. PubMed ID: 24954462
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination.
Talib N; Fronza M; Marschner CA; Thavendiranathan P; Karur GR; Hanneman K
J Cardiovasc Magn Reson; 2024 Summer; 26(1):101036. PubMed ID: 38479457
[TBL] [Abstract][Full Text] [Related]
12. Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditis.
Bohnen S; Radunski UK; Lund GK; Ojeda F; Looft Y; Senel M; Radziwolek L; Avanesov M; Tahir E; Stehning C; Schnackenburg B; Adam G; Blankenberg S; Muellerleile K
Eur Heart J Cardiovasc Imaging; 2017 Jul; 18(7):744-751. PubMed ID: 28329275
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric cardiac magnetic resonance imaging in pediatric and adolescent patients with acute myocarditis.
Isaak A; Bischoff LM; Faron A; Endler C; Mesropyan N; Sprinkart AM; Pieper CC; Kuetting D; Dabir D; Attenberger U; Luetkens JA
Pediatr Radiol; 2021 Dec; 51(13):2470-2480. PubMed ID: 34435226
[TBL] [Abstract][Full Text] [Related]
14. Cardiac MRI Depicts Immune Checkpoint Inhibitor-induced Myocarditis: A Prospective Study.
Faron A; Isaak A; Mesropyan N; Reinert M; Schwab K; Sirokay J; Sprinkart AM; Bauernfeind FG; Dabir D; Pieper CC; Heine A; Kuetting D; Attenberger U; Landsberg J; Luetkens JA
Radiology; 2021 Dec; 301(3):602-609. PubMed ID: 34581628
[TBL] [Abstract][Full Text] [Related]
15. Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance.
von Knobelsdorff-Brenkenhoff F; Schüler J; Dogangüzel S; Dieringer MA; Rudolph A; Greiser A; Kellman P; Schulz-Menger J
Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213448
[TBL] [Abstract][Full Text] [Related]
16. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure.
Bohnen S; Radunski UK; Lund GK; Kandolf R; Stehning C; Schnackenburg B; Adam G; Blankenberg S; Muellerleile K
Circ Cardiovasc Imaging; 2015 Jun; 8(6):. PubMed ID: 26015267
[TBL] [Abstract][Full Text] [Related]
17. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
Radunski UK; Lund GK; Säring D; Bohnen S; Stehning C; Schnackenburg B; Avanesov M; Tahir E; Adam G; Blankenberg S; Muellerleile K
Clin Res Cardiol; 2017 Jan; 106(1):10-17. PubMed ID: 27388331
[TBL] [Abstract][Full Text] [Related]
18.
Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
[TBL] [Abstract][Full Text] [Related]
19. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Cardiovascular Magnetic Resonance in Acute Myocarditis: Comparison of 2009 and 2018 Lake Louise Criteria With Endomyocardial Biopsy Confirmation.
Li S; Duan X; Feng G; Sirajuddin A; Yin G; Zhuang B; He J; Xu J; Yang W; Wu W; Sun X; Zhao S; Wang H; Teng Z; Lu M
Front Cardiovasc Med; 2021; 8():739892. PubMed ID: 34712710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
